Effects of D1 and D2 dopamine antagonists on heroin-trained drug discrimination.
Corrigall
W A
WA
Addiction Research Foundation, Toronto, Ontario, Canada.
Coen
K M
KM
D000818:Animals; D014150:Antipsychotic Agents; D001552:Benzazepines / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects*; D004193:Discrimination Learning / Q000187:drug effects*; D018492:Dopamine Antagonists; D004305:Dose-Response Relationship, Drug; D003932:Heroin / Q000494:pharmacology*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D013134:Spiperone / Q000494:pharmacology*
D014150:Antipsychotic Agents; D001552:Benzazepines; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D013134:Spiperone; D003932:Heroin